pneumocystis pneumonia

GPTKB entity

Statements (47)
Predicate Object
gptkbp:instance_of gptkb:pneumonia
gptkbp:associated_with gptkb:HIV/_AIDS
gptkbp:caused_by gptkb:Pneumocystis_jirovecii
gptkbp:community_health associated with HIV epidemic
important in transplant medicine
requires awareness in healthcare settings
gptkbp:complication respiratory failure
secondary infections
pulmonary hypertension
gptkbp:diagnosis CT scan
chest X-ray
early treatment improves outcomes
bronchoalveolar lavage
depends on immune status
risk of recurrence after treatment
sputum analysis
gptkbp:epidemiology more common in developing countries
incidence increases with age
associated with high mortality rates in untreated cases
gptkbp:first_described_by 1970s
https://www.w3.org/2000/01/rdf-schema#label pneumocystis pneumonia
gptkbp:is_common_in immunocompromised individuals
gptkbp:pathway affects alveoli
causes inflammation
characterized by foamy exudate
leads to impaired gas exchange
gptkbp:prevention prophylactic antibiotics
gptkbp:research_focus epidemiological studies
vaccine development
treatment optimization
understanding pathogenesis
improved diagnostic methods
gptkbp:risk_factor malnutrition
organ transplantation
chemotherapy
corticosteroid use
gptkbp:symptoms cough
fever
shortness of breath
gptkbp:treatment gptkb:pentamidine
gptkb:trimethoprim-sulfamethoxazole
corticosteroids
can be fatal if untreated
improved with treatment
antimicrobial therapy
gptkbp:bfsParent gptkb:HIV/_AIDS
gptkbp:bfsLayer 4